Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug CagriSema, wiping as much as $125 billion off its market value.
Britain's Boris Johnson has been referred to police over further potential breaches of lockdown rules during the COVID-19 pandemic, a charge the former prime minister's office portrayed as "yet another…